Clinigen Group PLC (CLIN) Sets New 1-Year High at $1,175.00
Clinigen Group PLC (LON:CLIN)’s share price hit a new 52-week high on Monday . The stock traded as high as GBX 1,175 ($15.51) and last traded at GBX 1,167 ($15.40), with a volume of 585,967 shares changing hands. The stock had previously closed at GBX 1,126 ($14.86).
CLIN has been the topic of several research reports. Peel Hunt reiterated an “add” rating and set a GBX 1,200 ($15.84) price objective on shares of Clinigen Group PLC in a report on Thursday, September 28th. Numis Securities Ltd lowered shares of Clinigen Group PLC to an “add” rating and set a GBX 1,100 ($14.52) target price on the stock. in a report on Tuesday, July 18th. Finally, Berenberg Bank started coverage on shares of Clinigen Group PLC in a report on Wednesday. They issued a “hold” rating and a GBX 1,200 ($15.84) target price on the stock. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of GBX 1,103 ($14.56).
The firm’s market cap is GBX 1.35 billion. The firm has a 50 day moving average price of GBX 1,108.97 and a 200-day moving average price of GBX 978.53.
Clinigen Group PLC (LON:CLIN) last issued its quarterly earnings results on Thursday, September 28th. The company reported GBX 41.80 ($0.55) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of GBX 41.20 ($0.54) by GBX 0.60 ($0.01). Clinigen Group PLC had a net margin of 0.70% and a return on equity of 0.98%. The company had revenue of £302.30 million during the quarter.
The firm also recently declared a dividend, which will be paid on Friday, December 1st. Investors of record on Thursday, November 9th will be given a dividend of GBX 3.40 ($0.04) per share. This is a boost from Clinigen Group PLC’s previous dividend of $1.60. This represents a yield of 0.32%. The ex-dividend date of this dividend is Thursday, November 9th.
In related news, insider Shaun Edward Chilton sold 100,000 shares of Clinigen Group PLC stock in a transaction dated Friday, October 13th. The shares were sold at an average price of GBX 1,150 ($15.18), for a total transaction of £1,150,000 ($1,517,550.80). Also, insider John Bacon sold 250,000 shares of Clinigen Group PLC stock in a transaction dated Monday, October 2nd. The shares were sold at an average price of GBX 1,093 ($14.42), for a total transaction of £2,732,500 ($3,605,832.67).
Clinigen Group PLC Company Profile
Receive News & Stock Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related stocks with our FREE daily email newsletter.